QMA

Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) — QMA analysis

Sector: Financial Services · Market cap: $525M · Price: $10.19 · Data as of 2026-10-23

54
/100
C
Composite grade
Higher score than 81% of 22,734 tracked stocks

A composite score of 54/100 places Drugs Made In America Acquisition II Corp. Ordinary Shares in the neutral band, higher score than 81% of 22,734 tracked stocks. The highest-scoring layer is Off-exchange trading (FINRA) / large flows; the lowest is Insider activity.

Analytical score, not investment advice. No score is an instruction or a guarantee. Past performance ≠ future results.
Share this analysis
𝕏in

What 7 data layers say about DMII

The composite fuses insiders, congressional trades, institutional 13F positions, fundamentals, momentum, seasonality and more into a single number.

LayerScore
Fundamental value (FVS)48/100
Technical trend (TSS)51/100
Relative strength (RS)52/100
Momentum (USS)38/100
Insider activity (IAS)0/100
Off-exchange trading (FINRA) / large flows (WHS)70/100
Institutional 13F (IFS)55/100

What does the QMA model currently show for Drugs Made In America Acquisition II Corp. Ordinary Shares?

The composite score is an entry point, not a signal. What matters is layer confluence — whether they point the same direction.

For DMII the layers diverge — some score high (Off-exchange trading (FINRA) / large flows), others low (Insider activity). The divergence is itself information: the model does not give a clear-cut picture. The score is an input into your own research, not a recommendation.

DMII insider & smart money activity

Over the recent period we record 3 reported insider purchases and 0 sales for DMII: only reported purchases, no sales. A description of the data layer, not an instruction.

How DMII compares

Similar stocks from the same sector:

Frequently asked questions

What is the composite score for DMII stock?

54/100 (grade C) as of 2026-10-23, fusing 7 data layers. An analytical score, not advice.

Are insiders buying DMII stock?

Over the recent period, reported: purchases 3, sales 0; trade value not reported. Insider activity: only reported purchases, no sales — a description of reported data, not a trade instruction.

Where can I see live DMII data?

Live DMII data and the full screener are part of full access. Registration is free with no card — trial full access, then the free plan with a delayed data sample.

Explore more — for free

The DMII score is just the start. Keep going free in the QMA magazine — analysis, tools and learning with no payment up front.

Free registration, no card — trial full access, then the free plan

Want the full DMII analysis with all layers and live data? Open DMII detail →

Data from SEC and public markets. QMA is an analytical tool, not a registered investment advisor. No content on this page is investment advice or an instruction to buy or sell. Past performance does not guarantee future results.

⚠️ Important Notice: QMA is an analytical and educational tool, not investment advice. Scores, detections and ratings are descriptive, not buy/sell instructions. QMA is not a registered investment advisor (SEC / FINRA / MiFID II / ČNB). Consult a licensed financial advisor before any investment. Past performance does not guarantee future results; all investments carry the risk of capital loss.

Operator: Jaroslav Vojtášek · IČO: 48783447 · Place of business: U Jízdárny 577, 747 64 Velká Polom, Czech Republic · Register: Sole trader registered in the Czech Trade Licensing Register · E-mail: [email protected]